Cargando…

The Clinical Efficacy of Platelet-Rich Plasma versus Conventional Drug Injection in the Treatment of Knee Osteoarthritis: A Study Protocol for a Randomized Controlled Trial

Knee osteoarthritis is a common chronic degenerative joint disease in middle-aged and elderly people. Intra-articular injection for the treatment of knee osteoarthritis is a regularly utilized nonsurgical treatment in modern medicine. Hyaluronic acid (HA) and platelet-rich plasma (PRP) are two frequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Qi, Hei, Xiaoyan, Zhu, Shiqiang, Tian, Xinbao, Chen, Yundong, Zhu, Ning, Zhang, Jinchen, Feng, Ping, Liu, Yujuan, Xing, Lijuan, Li, Xiaojun, Liu, Qiang, Li, Fengqiao, Li, Xiaolong, Lai, Zheying, Lin, Ruizhu, Xu, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153935/
https://www.ncbi.nlm.nih.gov/pubmed/35656456
http://dx.doi.org/10.1155/2022/8767137
_version_ 1784717937955831808
author Ma, Qi
Hei, Xiaoyan
Zhu, Shiqiang
Tian, Xinbao
Chen, Yundong
Zhu, Ning
Zhang, Jinchen
Feng, Ping
Liu, Yujuan
Xing, Lijuan
Li, Xiaojun
Liu, Qiang
Li, Fengqiao
Li, Xiaolong
Lai, Zheying
Lin, Ruizhu
Xu, Jianfeng
author_facet Ma, Qi
Hei, Xiaoyan
Zhu, Shiqiang
Tian, Xinbao
Chen, Yundong
Zhu, Ning
Zhang, Jinchen
Feng, Ping
Liu, Yujuan
Xing, Lijuan
Li, Xiaojun
Liu, Qiang
Li, Fengqiao
Li, Xiaolong
Lai, Zheying
Lin, Ruizhu
Xu, Jianfeng
author_sort Ma, Qi
collection PubMed
description Knee osteoarthritis is a common chronic degenerative joint disease in middle-aged and elderly people. Intra-articular injection for the treatment of knee osteoarthritis is a regularly utilized nonsurgical treatment in modern medicine. Hyaluronic acid (HA) and platelet-rich plasma (PRP) are two frequently employed intra-articular devices. Hyaluronic acid (HA) is an accepted nonsurgical treatment for symptomatic KOA, and platelet-rich plasma is a popular option in the treatment of KOA in recent years. The purpose of this research is to compare the efficacy and safety of intra-articular injection of platelet-rich plasma (PRP) versus hyaluronic acid (HA) on the pain score scale, knee function, and related inflammatory biomarkers in KOA patients using a clinical randomized controlled trial. Participants are being randomized into either the hyaluronic acid (HA) or into the platelet-rich plasma (PRP) group. All patients receive 4 weeks of treatment (once a week), and well-being support and quadriceps training (3 times a week). The primary outcomes are measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the visual analog scale (VAS). The secondary outcomes include the activities of daily living score, erythrocyte sedimentation rate, C-reactive protein testing, interleukin-6 levels, and X-ray examination. In order to monitor the occurrence of irregularities and abnormalities, patients are assessed at each visit, and restorative treatment is given if necessary. The results of this clinical trial will verify the efficacy of PRP and HA in the treatment of KOA and provide important evidence for the clinical treatment of KOA. The trial was enlisted at the Chinese Clinical Trial Registry on 26 September 2020 (ChiCTR2000038635).
format Online
Article
Text
id pubmed-9153935
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-91539352022-06-01 The Clinical Efficacy of Platelet-Rich Plasma versus Conventional Drug Injection in the Treatment of Knee Osteoarthritis: A Study Protocol for a Randomized Controlled Trial Ma, Qi Hei, Xiaoyan Zhu, Shiqiang Tian, Xinbao Chen, Yundong Zhu, Ning Zhang, Jinchen Feng, Ping Liu, Yujuan Xing, Lijuan Li, Xiaojun Liu, Qiang Li, Fengqiao Li, Xiaolong Lai, Zheying Lin, Ruizhu Xu, Jianfeng Evid Based Complement Alternat Med Research Article Knee osteoarthritis is a common chronic degenerative joint disease in middle-aged and elderly people. Intra-articular injection for the treatment of knee osteoarthritis is a regularly utilized nonsurgical treatment in modern medicine. Hyaluronic acid (HA) and platelet-rich plasma (PRP) are two frequently employed intra-articular devices. Hyaluronic acid (HA) is an accepted nonsurgical treatment for symptomatic KOA, and platelet-rich plasma is a popular option in the treatment of KOA in recent years. The purpose of this research is to compare the efficacy and safety of intra-articular injection of platelet-rich plasma (PRP) versus hyaluronic acid (HA) on the pain score scale, knee function, and related inflammatory biomarkers in KOA patients using a clinical randomized controlled trial. Participants are being randomized into either the hyaluronic acid (HA) or into the platelet-rich plasma (PRP) group. All patients receive 4 weeks of treatment (once a week), and well-being support and quadriceps training (3 times a week). The primary outcomes are measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the visual analog scale (VAS). The secondary outcomes include the activities of daily living score, erythrocyte sedimentation rate, C-reactive protein testing, interleukin-6 levels, and X-ray examination. In order to monitor the occurrence of irregularities and abnormalities, patients are assessed at each visit, and restorative treatment is given if necessary. The results of this clinical trial will verify the efficacy of PRP and HA in the treatment of KOA and provide important evidence for the clinical treatment of KOA. The trial was enlisted at the Chinese Clinical Trial Registry on 26 September 2020 (ChiCTR2000038635). Hindawi 2022-04-25 /pmc/articles/PMC9153935/ /pubmed/35656456 http://dx.doi.org/10.1155/2022/8767137 Text en Copyright © 2022 Qi Ma et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ma, Qi
Hei, Xiaoyan
Zhu, Shiqiang
Tian, Xinbao
Chen, Yundong
Zhu, Ning
Zhang, Jinchen
Feng, Ping
Liu, Yujuan
Xing, Lijuan
Li, Xiaojun
Liu, Qiang
Li, Fengqiao
Li, Xiaolong
Lai, Zheying
Lin, Ruizhu
Xu, Jianfeng
The Clinical Efficacy of Platelet-Rich Plasma versus Conventional Drug Injection in the Treatment of Knee Osteoarthritis: A Study Protocol for a Randomized Controlled Trial
title The Clinical Efficacy of Platelet-Rich Plasma versus Conventional Drug Injection in the Treatment of Knee Osteoarthritis: A Study Protocol for a Randomized Controlled Trial
title_full The Clinical Efficacy of Platelet-Rich Plasma versus Conventional Drug Injection in the Treatment of Knee Osteoarthritis: A Study Protocol for a Randomized Controlled Trial
title_fullStr The Clinical Efficacy of Platelet-Rich Plasma versus Conventional Drug Injection in the Treatment of Knee Osteoarthritis: A Study Protocol for a Randomized Controlled Trial
title_full_unstemmed The Clinical Efficacy of Platelet-Rich Plasma versus Conventional Drug Injection in the Treatment of Knee Osteoarthritis: A Study Protocol for a Randomized Controlled Trial
title_short The Clinical Efficacy of Platelet-Rich Plasma versus Conventional Drug Injection in the Treatment of Knee Osteoarthritis: A Study Protocol for a Randomized Controlled Trial
title_sort clinical efficacy of platelet-rich plasma versus conventional drug injection in the treatment of knee osteoarthritis: a study protocol for a randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153935/
https://www.ncbi.nlm.nih.gov/pubmed/35656456
http://dx.doi.org/10.1155/2022/8767137
work_keys_str_mv AT maqi theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT heixiaoyan theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT zhushiqiang theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT tianxinbao theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT chenyundong theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT zhuning theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT zhangjinchen theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT fengping theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT liuyujuan theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT xinglijuan theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT lixiaojun theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT liuqiang theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT lifengqiao theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT lixiaolong theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT laizheying theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT linruizhu theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT xujianfeng theclinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT maqi clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT heixiaoyan clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT zhushiqiang clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT tianxinbao clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT chenyundong clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT zhuning clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT zhangjinchen clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT fengping clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT liuyujuan clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT xinglijuan clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT lixiaojun clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT liuqiang clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT lifengqiao clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT lixiaolong clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT laizheying clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT linruizhu clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial
AT xujianfeng clinicalefficacyofplateletrichplasmaversusconventionaldruginjectioninthetreatmentofkneeosteoarthritisastudyprotocolforarandomizedcontrolledtrial